Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888429870> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2888429870 endingPage "210" @default.
- W2888429870 startingPage "204" @default.
- W2888429870 abstract "Objective: To summarize formulary-relevant issues for follow-on insulins approved through the Food and Drug Administration (FDA) 505(b)(2) approval pathway (Basaglar and Admelog). Data Sources: A search of the MEDLINE database was performed for articles pertaining to clinical and formulary considerations for follow-on insulin products through July 2018. Study Selection and Data Extraction: All clinical trials used in the 505(b)(2) approval process for follow-on insulin glargine and insulin lispro products were included and summarized. Data Synthesis: Follow-on insulin glargine and insulin lispro products have been recently approved as the first lower-cost alternatives to innovator insulin products. The follow-on insulins were approved via the 505(b)(2) pathway, making them neither generics nor biosimilars. Current data do not suggest any clinically relevant differences between the follow-on insulins and their respective innovator products. Clinicians should be aware that follow-on insulins will be reclassified as biologic products in the year 2020. Relevance to Patient Care and Clinical Practice: This article provides information about currently available follow-on insulin products that were approved through the 505(b)(2) pathway, including product characteristics and efficacy and safety data. These products will likely be considered for both clinical use and formulary placement because of their potentially lower cost compared with innovator products. Conclusions: Follow-on insulin products approved through the 505(b)(2) pathway are supported by robust efficacy and safety data. As new follow-on insulins are approved and the regulatory change that will occur with these products in 2020 approaches, formulary decisions and clinical policies (eg, substitution) will continue to be revisited." @default.
- W2888429870 created "2018-08-31" @default.
- W2888429870 creator A5043311902 @default.
- W2888429870 creator A5078238018 @default.
- W2888429870 date "2018-08-20" @default.
- W2888429870 modified "2023-10-14" @default.
- W2888429870 title "Formulary Considerations for Insulins Approved Through the 505(b)(2) “Follow-on” Pathway" @default.
- W2888429870 cites W1511241035 @default.
- W2888429870 cites W1605338960 @default.
- W2888429870 cites W1968620668 @default.
- W2888429870 cites W2030199744 @default.
- W2888429870 cites W2089190513 @default.
- W2888429870 cites W2111331117 @default.
- W2888429870 cites W2114938391 @default.
- W2888429870 cites W2134380349 @default.
- W2888429870 cites W2140451842 @default.
- W2888429870 cites W2175197887 @default.
- W2888429870 cites W2291327653 @default.
- W2888429870 cites W2315065380 @default.
- W2888429870 cites W2336913991 @default.
- W2888429870 cites W2512794097 @default.
- W2888429870 cites W2611515985 @default.
- W2888429870 cites W2737760301 @default.
- W2888429870 cites W2751771383 @default.
- W2888429870 cites W2775192218 @default.
- W2888429870 cites W2784554518 @default.
- W2888429870 cites W2785389980 @default.
- W2888429870 cites W2802301328 @default.
- W2888429870 cites W2804128026 @default.
- W2888429870 cites W2916840078 @default.
- W2888429870 cites W2917193598 @default.
- W2888429870 cites W3092065440 @default.
- W2888429870 doi "https://doi.org/10.1177/1060028018795834" @default.
- W2888429870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30122087" @default.
- W2888429870 hasPublicationYear "2018" @default.
- W2888429870 type Work @default.
- W2888429870 sameAs 2888429870 @default.
- W2888429870 citedByCount "6" @default.
- W2888429870 countsByYear W28884298702020 @default.
- W2888429870 countsByYear W28884298702021 @default.
- W2888429870 countsByYear W28884298702022 @default.
- W2888429870 crossrefType "journal-article" @default.
- W2888429870 hasAuthorship W2888429870A5043311902 @default.
- W2888429870 hasAuthorship W2888429870A5078238018 @default.
- W2888429870 hasConcept C100406419 @default.
- W2888429870 hasConcept C111919701 @default.
- W2888429870 hasConcept C126322002 @default.
- W2888429870 hasConcept C177713679 @default.
- W2888429870 hasConcept C2776473838 @default.
- W2888429870 hasConcept C2776486108 @default.
- W2888429870 hasConcept C2779306644 @default.
- W2888429870 hasConcept C2779920387 @default.
- W2888429870 hasConcept C2780668416 @default.
- W2888429870 hasConcept C3018890749 @default.
- W2888429870 hasConcept C3019948211 @default.
- W2888429870 hasConcept C34974158 @default.
- W2888429870 hasConcept C41008148 @default.
- W2888429870 hasConcept C4892016 @default.
- W2888429870 hasConcept C59491497 @default.
- W2888429870 hasConcept C71924100 @default.
- W2888429870 hasConcept C98274493 @default.
- W2888429870 hasConceptScore W2888429870C100406419 @default.
- W2888429870 hasConceptScore W2888429870C111919701 @default.
- W2888429870 hasConceptScore W2888429870C126322002 @default.
- W2888429870 hasConceptScore W2888429870C177713679 @default.
- W2888429870 hasConceptScore W2888429870C2776473838 @default.
- W2888429870 hasConceptScore W2888429870C2776486108 @default.
- W2888429870 hasConceptScore W2888429870C2779306644 @default.
- W2888429870 hasConceptScore W2888429870C2779920387 @default.
- W2888429870 hasConceptScore W2888429870C2780668416 @default.
- W2888429870 hasConceptScore W2888429870C3018890749 @default.
- W2888429870 hasConceptScore W2888429870C3019948211 @default.
- W2888429870 hasConceptScore W2888429870C34974158 @default.
- W2888429870 hasConceptScore W2888429870C41008148 @default.
- W2888429870 hasConceptScore W2888429870C4892016 @default.
- W2888429870 hasConceptScore W2888429870C59491497 @default.
- W2888429870 hasConceptScore W2888429870C71924100 @default.
- W2888429870 hasConceptScore W2888429870C98274493 @default.
- W2888429870 hasIssue "2" @default.
- W2888429870 hasLocation W28884298701 @default.
- W2888429870 hasLocation W28884298702 @default.
- W2888429870 hasOpenAccess W2888429870 @default.
- W2888429870 hasPrimaryLocation W28884298701 @default.
- W2888429870 hasRelatedWork W1971785230 @default.
- W2888429870 hasRelatedWork W2016258403 @default.
- W2888429870 hasRelatedWork W2089190513 @default.
- W2888429870 hasRelatedWork W2160880263 @default.
- W2888429870 hasRelatedWork W2888429870 @default.
- W2888429870 hasRelatedWork W3031316986 @default.
- W2888429870 hasRelatedWork W3141865038 @default.
- W2888429870 hasRelatedWork W3216095744 @default.
- W2888429870 hasRelatedWork W4285613007 @default.
- W2888429870 hasRelatedWork W2261344402 @default.
- W2888429870 hasVolume "53" @default.
- W2888429870 isParatext "false" @default.
- W2888429870 isRetracted "false" @default.
- W2888429870 magId "2888429870" @default.
- W2888429870 workType "article" @default.